title: Immune recognition at the maternal-fetal interface: overview.
abstract: Trophoblast antigens at the maternal-fetal interface that are capable of stimulating maternal immune responses have been studied. Candidates are blood group I and P, HLA, Fc gamma-receptors, TLX, and phospholipids. Antigens I and P on trophoblast have been implicated in pregnancy loss but incompatible i,p mothers are rare. HLA-G is expressed on cytotrophoblast; however, no evidence for HLA-G allotypy or maternal responses to these molecules exists, although HLA-G has been implicated in recruitment of suppressor T cells. Receptors for IgG (Fc gamma-RI, Fc gamma-RII and Fc gamma-III) are present on trophoblast but allotypy is limited to the NA1-NA2 antigen system associated with Fc gamma-RIII on neutrophils. Maternal Fc-gamma R blocking antibodies have been linked to pregnancy success. The TLX alloantigen system was described by using xenogeneic antisera. Idiotype-antiidiotype regulated maternal responses to TLX are proposed as necessary for successful pregnancy. Several putative TLX monoclonal antibodies (Mab) recognize a regulator of complement activation called MCP (membrane cofactor protein, or CD46). Mab to MCP do not exhibit allotypy. Syncytial and cytotrophoblastic membranes are rich sources of MCP. Preliminary data suggest that a conformational site induced by C3b (iC3) binding to MCP may be responsible for TLX allotypy. Certain pregnancy loss patients produce antiphospholipid antibodies (aPA). Some investigators believe that aPA recognize a plasma protein cofactor, beta 2 GPI and not phospholipid per se. We produced three Mab specific for beta 2 GPI, one of which fails to recognize beta 2 GPI bound to phospholipid [corrected].(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Center for Reproduction and Transplantation Immunology, Methodist Hospital of Indiana, Indianapolis 46202.
authors.forename: J A
authors.initials: JA
authors.lastname: McIntyre
mesh_terms: D015703:Antigens, CD / Q000276:immunology; D005260:Female; D005333:Fetus / Q000276:immunology*; D006023:Glycoproteins / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007519:Isoantigens / Q000276:immunology; D008431:Maternal-Fetal Exchange; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000276:immunology; D010743:Phospholipids / Q000276:immunology; D011247:Pregnancy / Q000276:immunology*; D011961:Receptors, Fc / Q000276:immunology; D014327:Trophoblasts / Q000276:immunology*; D053482:beta 2-Glycoprotein I
chemical_list: D015703:Antigens, CD; C497857:CD46 protein, human; D006023:Glycoproteins; D006680:HLA Antigens; D007519:Isoantigens; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D010743:Phospholipids; D011961:Receptors, Fc; D053482:beta 2-Glycoprotein I; C055067:trophoblast-lymphocyte cross-reactive antigens